// App-Quantinova.ai

: RISK OF THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA ACCORDING TO THE JAK2 V617F ALLELE BURDEN

Researchers

Presenter

  • Sung Hwa Bae

Principal Investigators

  • Jun Yeb Nam

  • A-Jin Lee

  • Jaehum Yun

  • Sang-Gyung Kim

  • Won Sik Lee

Medical Centers

  • Internal Medicine,Daegu Catholic University Hospital,Daegu,Korea, Republic Of

  • Internal Medicine,Daegu Catholic University Hospital,Daegu,Korea, Republic Of

  • Internal Medicine, Haeundae Paik Hospital, Busan, Korea, Republic of

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A